Retraction of: Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Via Downregulation of the Extracellular Matrix-Receptor Interaction Pathway (doi: 10.1089/cbr.2020.4429)

Abstract

Cancer Biotherapy & RadiopharmaceuticalsVol. 38, No. 1 Retraction NoticeOpen AccessRetraction of: Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Via Downregulation of the Extracellular Matrix-Receptor Interaction Pathway (doi: 10.1089/cbr.2020.4429)This article retracts the following:RETRACTED: Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Via Downregulation of the Extracellular Matrix–Receptor Interaction PathwayPublished Online:1 Feb 2023https://doi.org/10.1089/cbr.2020.4429.retractAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail The Editor-in-Chief of Cancer Biotherapy and Radiopharmaceuticals officially retracts the article entitled, “C Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Via Downregulation of the Extracellular Matrix-Receptor Interaction Pathway,” by Yuanyuan Gu, Ke Huang, Min Zhang, Fang Teng, Lili Ge, Juan Zhou, Juan Xu, and Xuemei Jia (Cancer Biother Radiopharm, 37(7):2022;580–588; doi: 10.1089/cbr.2020.4429).The corresponding author of the paper, Dr. Xuemei Jia, contacted the journal's editorial office requesting to replace Figure 3K in the published article, stating: ”An error was identified in Fig. 3K, which was made by careless figure assembling. These experiments were repeated by two students for at least three times…. These corrections do not change the conclusion of this article. All authors agree to the correction and apologize for any inconvenience caused.” [sic]An independent analysis of the figures was performed which confirmed image manipulation, raising doubts about the originality of data and the reliability of the published results.Dr. Xuemei Jia, as well as all coauthors, were notified via email of the decision to retract, utilizing the email addresses provided to the journal at the time of submission in 2020, though no responses were received.The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the veracity of scientific literature and the community it serves.FiguresReferencesRelatedDetailsRelated articlesRETRACTED: Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Via Downregulation of the Extracellular Matrix–Receptor Interaction Pathway8 Sep 2022Cancer Biotherapy & Radiopharmaceuticals Volume 38Issue 1Feb 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Retraction of: Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Via Downregulation of the Extracellular Matrix-Receptor Interaction Pathway (doi: 10.1089/cbr.2020.4429).Cancer Biotherapy and Radiopharmaceuticals.Feb 2023.79-79.http://doi.org/10.1089/cbr.2020.4429.retractcreative commons licensePublished in Volume: 38 Issue 1: February 1, 2023Online Ahead of Print:January 12, 2023PDF download